Press Releases
Mar. 26, 2018 Bioasis Announces Key Strategic Appointment to its Senior Leadership Team with Addition of Caroline Hill, Ph.D., Leading Research & Development Operations
VANCOUVER, British Columbia & GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical company with a proprietary blood-brain barrier platform delivery technology focused on development of therapeutics for the treatment of brain cancers and neurodegenerative diseases, today announced a key strategic appointment to its senior leadership team with the addition of Caroline Hill, Ph.D.,… Read more »
Mar. 21, 2018 Bioasis Appoints Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE as Chair of the Board of Directors
Dr. Rathjen is the Chief Executive Officer and Managing Director of Bionomics in Adelaide, Australia; Dr. Rathjen joined the Bioasis Board in September 2017
Feb. 6, 2018 Bioasis to Present at the 20th Annual BIO CEO & Investor Conference
VANCOUVER, British Columbia & GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI) announced today that it will present at the 20th Annual BIO CEO & Investor Conference, to be held February 12-13, 2018 at the New York Marriott Marquis. Mark Day, Ph.D., president and chief executive officer, Bioasis, will present at the BIO CEO &… Read more »
Jan. 30, 2018 Bioasis Announces Filing of Quarterly Financial Statements and MD&A
VANCOUVER, British Columbia & GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier (BBB) and into the central nervous system for the treatment of neurological diseases and disorders, today announced that it has filed its unaudited quarterly financial statements and management’s discussion and… Read more »
Jan. 8, 2018 updated: Bioasis to Present at the 2018 Biotech Showcase Annual Conference
Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI) announced today that it will present at the Biotech Showcase™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.
Dec. 4, 2017 Bioasis Implements Transition Plan for Its Board of Directors
Company intends to selectively replace outgoing directors with new, highly qualified, independent candidates
Oct. 10, 2017 Bioasis Establishes U.S. Presence with Office in Connecticut
The Company also launches new website bioasis.us
Oct. 2, 2017 biOasis Appoints Christopher P. Lowe, M.B.A. as Chief Financial Officer and Board Advisor
Lowe brings extensive experience serving as an executive and board member for early, research-stage biotechnology companies
Sep. 21, 2017 biOasis Announces Voting Results for 2017 Annual Meeting
The Company welcomes new board members Dr. Nancy Stagliano, Dr. Deborah Rathjen and Dr. Maha Radhakrishnan
Sep. 18, 2017 biOasis Announces Rob Hutchison, Founder, to Retire as Chairman & Board Member
Additional Board & Leadership Team Changes Also Announced